Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology
Bharti MacknessPaul Holvoet

Abstract

The metabolic syndrome is typified by obesity, dyslipidemia, diabetes, hypertension, increased oxidative stress, and accelerated atherosclerosis. Paraoxonase1 (PON1), a high-density lipoprotein (HDL)-associated antioxidant enzyme that prevents the oxidation of low-density lipoprotein (LDL), is low in the metabolic syndrome. We used adenovirus-mediated PON1 gene transfer (AdPON1) to overexpress human PON1 in mice with combined leptin and LDL receptor deficiency, a model of metabolic syndrome. PON1 activity, plasma lipids, the titer of autoantibodies against malondialdehyde (MDA)-modified LDL, and atherosclerosis in AdPON1 mice were compared with these in mice that received a control recombinant adenovirus (AdRR5). PON1 activity was increased 4.4-fold (P<0.001) in AdPON1 mice (N = 12), whereas in AdRR5 mice (N = 11) activity did not change. Expressing human PON1 significantly reduced the total plaque volume, the volume of plaque macrophages, and of plaque-associated oxidized LDL. It increased the percentage of smooth muscle cells in the plaques. Expressing human PON1 lowered the titer of autoantibodies against MDA-modified LDL, a proxy for oxidized LDL in mice. It had no overall effect on plasma total cholesterol and triglyceride...Continue Reading

References

Jul 1, 1995·The Journal of Clinical Investigation·N AbateS M Grundy
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
Jun 27, 1998·Biochemical and Biophysical Research Communications·B MacknessM I Mackness
Jan 19, 2002·Biochemical and Biophysical Research Communications·Michael N OdaTrudy M Forte
Aug 2, 2002·Current Opinion in Lipidology·Bharti MacknessMichael I Mackness
May 21, 2003·Circulation·Bharti MacknessMichael Mackness
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Mariano SentíJaume Marrugat
May 18, 2004·Biochemical and Biophysical Research Communications·Bharti MacknessMike Mackness
Sep 30, 2004·Free Radical Biology & Medicine·Michael Aviram, Mira Rosenblat
Dec 21, 2004·Free Radical Biology & Medicine·Carey J NgSrinivasa T Reddy
Feb 3, 2005·The Journal of Clinical Endocrinology and Metabolism·Marie-Claude Blatter GarinRichard W James
Jul 8, 2005·The New England Journal of Medicine·Sotirios TsimikasPeter B Berger

❮ Previous
Next ❯

Citations

Jun 25, 2013·The British Journal of Nutrition·A I RupérezC M Aguilera
Dec 17, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·B GeeraertP Holvoet
Aug 27, 2011·Antioxidants & Redox Signaling·Zhi-Gang SheDe-Pei Liu
Mar 29, 2008·Metabolic Syndrome and Related Disorders
Feb 19, 2008·Cardiovascular Research·Gaia SpinettiPaolo Madeddu
Jun 25, 2009·Current Opinion in Lipidology·Handrean SoranPaul Durrington
Mar 24, 2007·Circulation Research·Diana M ShihSrinivasa T Reddy
Sep 9, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Richard W James
Sep 2, 2008·Clinical Chemistry and Laboratory Medicine : CCLM·Alejandro Gugliucci
Jun 8, 2012·Journal of Cardiovascular Medicine·Muiruri MachariaTandi E Matsha
Nov 28, 2012·North American Journal of Medical Sciences·Dmitry LitvinovMahdi Garelnabi
Oct 1, 2011·International Journal of Vascular Medicine·Boudewijn KlopManuel Castro Cabezas
Apr 12, 2013·Expert Opinion on Therapeutic Targets·Mike Mackness, Bharti Mackness
Jul 30, 2014·Journal of Toxicology and Environmental Health. Part a·G GinsbergP Lewandowski
Apr 29, 2008·Free Radical Biology & Medicine·Judit MarsillachJordi Camps
Nov 26, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jieying DingFuxiang Chen
Oct 3, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Dieuwke De KeyzerEwa Ninio
Oct 31, 2018·The American Journal of Clinical Nutrition·Eke G GruppenRobin P F Dullaart
May 6, 2019·Antioxidants·Débora LevySérgio Paulo Bydlowski
Mar 4, 2009·Critical Reviews in Clinical Laboratory Sciences·Jordi CampsJorge Joven
Jan 15, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Henning HagmannPaul Thomas Brinkkoetter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.